Lorraine Adam
Rheumatology Portfolio Lead,Uk,Roi & Nordics @ Eli Lilly and Company
About Lorraine Adam
Lorraine Adam serves as the Rheumatology Portfolio Lead for Eli Lilly and Company in the UK, ROI, and Nordics, a position she has held since 2019. She has extensive experience in sales and marketing roles across various pharmaceutical companies, including GSK and Daiichi Sankyo.